Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1973 Aug;1:103–107.

Immune Responses to Tumour and Embryo Cells in Patients with Mammary Carcinoma

G Della Porta, S Canevari, G Fossati
PMCID: PMC2149079  PMID: 4804274

Abstract

Cytotoxicity microassays were used to study cellular and humoral responses of patients with breast carcinoma against in vitro cultured target cells of breast carcinomata and of human embryos. Peripheral lymphocytes were cytotoxic on both target cell types, whereas sera exerted a complement-dependent cytotoxicity on breast cancer cells only. The immunosensitivity of the breast cancer cells to patient lymphocytes was augmented by restraining cell growth before test with a decreased quantity of foetal calf serum.

Full text

PDF
103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen V., Bjerrum O., Bendixen G., Schiodt T., Dissing I. Effect of autologous mammary tumour extracts on human leukocyte migration in vitro. Int J Cancer. 1970 May 15;5(3):357–363. doi: 10.1002/ijc.2910050308. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Glaves D., Vose B. M. Embryonic antigen expression in chemically induced rat hepatomas and sarcomas. Int J Cancer. 1972 Sep 15;10(2):233–243. doi: 10.1002/ijc.2910100202. [DOI] [PubMed] [Google Scholar]
  3. Boiocchi M., Colnaghi M. I., Cascinelli N. Immunogenicità specifica nel coniglio di estratti di carcinoma mammario umano. Tumori. 1972 May-Jun;58(3):157–163. doi: 10.1177/030089167205800304. [DOI] [PubMed] [Google Scholar]
  4. Charney J., Moore D. H. Neutralization of murine mammary tumour virus by sera of women with breast cancer. Nature. 1971 Feb 26;229(5287):627–628. doi: 10.1038/229627a0. [DOI] [PubMed] [Google Scholar]
  5. Colnaghi M. I., Della Porta G. Evidence for virus-related and unrelated antigens on murine lymphomas induced by chemical carcinogens. J Natl Cancer Inst. 1973 Jan;50(1):173–180. doi: 10.1093/jnci/50.1.173. [DOI] [PubMed] [Google Scholar]
  6. Edynak E. M., Hirshaut Y., Bernhard M., Trempe G. Fluorescent antibody studies of human breast cancer. J Natl Cancer Inst. 1972 Apr;48(4):1137–1143. [PubMed] [Google Scholar]
  7. Fossati G., Canevari S., Della Porta G., Balzarini G. P., Veronesi U. Cellular immunity to human breast carcinoma. Int J Cancer. 1972 Sep 15;10(2):391–396. doi: 10.1002/ijc.2910100221. [DOI] [PubMed] [Google Scholar]
  8. Fossati G., Colnaghi M. I., Porta G. D., Cascinelli N., Veronesi U. Cellular and humoral immunity against human malignant melanoma. Int J Cancer. 1971 Sep 15;8(2):344–350. doi: 10.1002/ijc.2910080221. [DOI] [PubMed] [Google Scholar]
  9. Harlozinska A., Albert Z., Richter R., Singer Z., Salwa J. Humoral cross immunity in patients with malignant tumors. Arch Immunol Ther Exp (Warsz) 1971;19(6):835–849. [PubMed] [Google Scholar]
  10. Ménard S., Colnaghi M. I., Della Porta G. In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene. Cancer Res. 1973 Mar;33(3):478–481. [PubMed] [Google Scholar]
  11. Segall A., Weiler O., Genin J., Lacour J., Lacour F. In vitro study of cellular immunity against autochthonous human cancer. Int J Cancer. 1972 Mar 15;9(2):417–425. doi: 10.1002/ijc.2910090221. [DOI] [PubMed] [Google Scholar]
  12. Taylor G., Odili J. L. Tumour specific T-like antigen of human breast carcinoma. Br J Cancer. 1970 Sep;24(3):447–453. doi: 10.1038/bjc.1970.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ting C. C., Lavrin D. H., Shiu G., Herberman R. B. Expression of fetal antigens in tumor cells. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1664–1668. doi: 10.1073/pnas.69.7.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wolberg W. H. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers. Cancer Res. 1971 Jun;31(6):798–802. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES